drugset / Trial / NCT02825290

Modified Luteal Support for Frozen-Thawed Embryo Transfer - A Prospective Study

NCT02825290

Phase 4 Unknown 62 enrolled Sheba Medical Center
RandomizedParallel-groupDouble-blindTreatment

Summary

This study evaluates the outcomes of frozen-thawed embryo transfer (FET) success rate with modified luteal support - addition of a single injection of HCG and GnRH-agonist, on day of ET and 4 days later, respectively vs. traditional luteal support with vaginal progesterone only in ovulating women.

Timeline

Start
2016-07
Primary completion
2017-06
Completion
2017-06

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Ovidrel Protein / enzyme biologic 250 ug
Subject Triptorelin Other / unclassified 0.1 mg

Indications

No indication recorded.